The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing CyclinD1 have mistakenly been duplicated over the Western blot bands intended to represent SGK.
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Authors
Man-Qing Cao A-Bin You Xiao-Dong Zhu Wei Zhang Yuan-Yuan Zhang Shi-Zhe Zhang Kei-wei Zhang Hao Cai Wen-Kai Shi Xiao-Long Li Kang-Shuai Li Dong-Mei Gao De-Ning Ma Bo-Gen Ye Cheng-Hao Wang Cheng-Dong Qin Hui-Chan Sun Ti Zhang Zhao-You Tang
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.